Reshaping How Scientists Explore the Physical Behaviour of Living Systems

Optical trapping and manipulation, which is the use of precisely shaped laser beams to hold, rotate, and measure microscopic structures, is reshaping how scientists explore the physical behaviour of living systems. These light‑driven tools allow researchers to quantify forces, observe rapid motions, and detect subtle mechanical changes inside cells at extremely small scales. Many of these measurements were previously out of reach, yet they are crucial for understanding how cells function, adapt and respond to stress or disease triggers. 

At The University of Queensland, the Rubinsztein‑Dunlop lab is at the forefront of this work. Dr Mark Watson is one of the researchers expanding what optical tweezers can do, having recently completed his PhD, Mark is continuing to advance the methods. His specialty lies in rotational and ballistic optical tweezers, which are platforms that can track the rotation of microscopic probes at exceptionally high speeds. These techniques allow scientists to capture dynamic processes in cell‑like environments on millisecond timescales, revealing biological activity that happens too quickly for many conventional tools to detect.

A major focus of Mark’s research is improving how we measure the physical properties of tiny biological environments. Using rotational optical tweezers he has developed targeted approaches to measure the fluid properties within cells by using light to control and twist a microscopic spherical probe. These measurements reveal physical signatures that provide clues about how cells move, change shape and perform their functions. Mark’s published studies show these tools in action in living cells and soft biological materials, highlighting their potential to uncover early signs of changes linked to health or disease.

Mechanical properties inside cells, such as viscosity, stiffness and force transmission, are central to processes including cell division, development, immune responses and disease progression. Tools that can measure these properties directly and in real time give scientists a window into how life operates at the smallest scales. Mark’s work enables exactly this – fast, sensitive and minimally disruptive measurements that can capture the physical “early warning signs” of how a cell is changing. These capabilities are essential for studying disease mechanisms, testing drugs and uncovering how subtle physical shifts influence biological behaviour.

As QUBIC develops quantum‑enhanced sensing and imaging technologies, high‑precision optical trapping systems will form a vital bridge between classical photonics and emerging quantum tools. Mark’s improvements to stability, bandwidth and calibration help ensure these platforms are ready for integration with quantum light sources and quantum‑enabled readouts, future techniques that promise to reveal biological processes with unprecedented sensitivity.

Continuing as a postdoctoral researcher in the Rubinsztein‑Dunlop lab, Mark is now extending his work into new regimes where optical manipulation is combined with faster detection, new forms of structured light and emerging approaches from quantum photonics. The application of his research is guided by close collaboration with cell biologists across QUBIC to determine which biological problems to tackle and what further developments are needed. These developments will contribute directly to QUBIC’s mission to create the next generation of precision tools for understanding life at its most fundamental scales.

Quantum Breakthrough Could Transform Heart Disease Diagnosis in Australia

Heart disease remains the leading cause of death worldwide, and early, accurate diagnosis is critical to saving lives. Researchers at the ARC Centre of Excellence in Quantum Biotechnology (QUBIC) have taken a major step toward that goal by developing a quantum mid-infrared imaging approach that shows promise for distinguishing healthy from diseased heart tissue at the molecular level. This achievement, delivered through the Australian Government’s $36 million Critical Technology Challenge Program (CTCP), moves the technology closer to real-world use and positions Australia at the forefront of quantum-enabled health innovation.

The project demonstrates how quantum technologies can provide precise, non-invasive insights into heart health, paving the way for faster and more accurate diagnosis. It also marks progress toward prototype development, advancing beyond laboratory validation.

“By showing that quantum mid-infrared imaging can identify disease signatures in heart tissue, we’ve opened a pathway to practical diagnostic tools that could transform cardiovascular care,” says Professor Irina Kabakova, project lead at the University of Technology Sydney.

How the Technology Works
Infrared light can reveal the unique “fingerprints” of molecules because proteins, lipids, and other biomolecules absorb light at specific wavelengths. The mid-infrared range is particularly powerful for detecting these vibrational signatures, which change when tissue becomes diseased. QUBIC’s approach uses quantum-generated entangled photons to probe samples with high sensitivity and without dyes or labels. This enables label-free imaging and spectroscopy that can detect subtle molecular changes in tissue, such as those linked to heart disease, potentially allowing earlier and more accurate diagnosis.

The work is led by a cross-disciplinary team at UTS, including Professor Irina Kabakova, an expert in optical biomedical systems; Professor Alexander Solntsev, a leader in quantum optics and photonics; A/Prof Lana McClements, an expert in cardiovascular health, and Dr Isa Ahmadalidokht, who specialises in quantum spectroscopy and microscopy for diagnostics. Their combined expertise is enabling the transition from fundamental research toward applied health technology.

About the Critical Technology Challenge Program
The Critical Technology Challenge Program is a $36 million initiative under Australia’s National Quantum Strategy, designed to accelerate commercialisation of quantum technologies by moving them from early-stage readiness toward deployment and adoption. Round 1 Challenges included improving medical imaging and sensors for disease diagnosis, aligning directly with QUBIC’s heart disease spectroscopy project.

Bringing quantum to life
Quantum technologies are unlocking new frontiers in drug discovery, biomedical imaging, neuroscience and clean energy. Global investment in quantum technologies has already exceeded $55 billion, with the market projected to reach $106 billion by 2040. Life sciences are emerging as one of the most promising application areas, with quantum computing alone estimated to create $200–$500 billion in value by 2035, particularly through breakthroughs in drug discovery, diagnostics, and molecular simulation.

About QUBIC
The ARC Centre of Excellence in Quantum Biotechnology (QUBIC) is the world’s first national centre at the intersection of quantum science and biotechnology. QUBIC is developing next-generation quantum tools – including brain imagers and single-protein sensors – to tackle major challenges in health, biosecurity, energy, and agriculture. QUBIC’s research institutions include the University of Technology Sydney, University of Wollongong, The University of Queensland, the University of Melbourne, and Flinders University, and partners with leading industry, government, and international institutions.

Engineering Surfaces to Unlock Reliable Quantum Sensing

Quantum sensing promises measurement capabilities that far exceed classical technologies. Using quantum properties of matter, quantum sensors can detect extremely small magnetic, electrical and thermal signals, creating new opportunities across materials science, energy systems, health, advanced manufacturing, and the study of molecular and non‑equilibrium biological systems.

Quantum sensors are so sensitive that interference from their own surfaces overwhelms the signals they are designed to measure. Until this problem is solved, quantum sensing remains fragile, difficult to scale, and largely confined to controlled laboratory experiments.

In work published in ACS Nano, QUBIC Chief Investigator Associate Professor David Simpson and collaborators directly addressed this challenge by engineering the surface of fluorescent nanodiamonds, which are a leading solid‑state quantum sensing platform.

Nanodiamonds containing nitrogen‑vacancy (NV) centres can operate at room temperature and offer nanometre‑scale spatial resolution. However, when these quantum defects are positioned close to the nanodiamond surface – a requirement for high‑resolution sensing – surface‑induced noise rapidly degrades performance. This surface noise has been a persistent barrier to practical quantum sensing.

By deliberately modifying nanodiamond surface chemistry and applying ultra‑thin, uniform silica coatings, the researchers suppressed surface‑generated noise and extended spin relaxation times into the millisecond regime, significantly improving the stability and performance of nanodiamond quantum sensors.

Crucially, this work demonstrates that stabilising quantum sensor performance can be achieved through materials engineering, without reliance on complex quantum control techniques. By clearly linking surface chemistry to quantum behaviour, Associate Professor Simpson and his team transformed surface modification from trial and error into a method that can be deliberately designed and optimised.

This capability is essential for quantum sensing in complex, dynamic environments that demand extreme spatial resolution, such as observing how new materials behave at the nanoscale, monitoring chemical reactions as they happen, improving energy technologies like batteries, and studying molecular‑scale processes as they unfold.

For QUBIC, this research strengthens Centre objectives by delivering a robust, scalable quantum sensing platform that underpins translation across biotechnology, including agriculture, biosecurity, clean energy, and health.

Read the paper here: Functionalized Fluorescent Nanodiamonds with Millisecond Spin Relaxation Times

Heat-Activated Imaging: New NIR-II Material Glows for a Longer Lifetime

Seeing deep into the brain without harming delicate tissue is one of the biggest challenges in medical imaging. Researchers from QUBIC at the University of Technology Sydney have developed a new material that could help, one that glows longer and more stably as temperatures rise.

Published in Nano Letters, the material emits long-lasting near-infrared (NIR-II) light, which is ideal for deep-tissue imaging. Unlike traditional materials that fade when they heat up, this one becomes more luminous, making it easier to see what’s happening inside the body, potentially useful during surgery or in areas where temperature changes are common.

This research supports QUBIC’s mission to develop quantum-enabled technologies that reveal the inner workings of living systems. The material leverages the quantum properties of lanthanide ions, pairing special energy levels of different ions to enable more efficient energy transfer at higher temperatures. This design turns thermal fading, a long-standing problem, into an advantage, allowing for clearer, more stable imaging when it’s needed most.

By advancing the fundamental understanding of energy transfer in lanthanide systems, this work contributes to the development of next-generation imaging materials that could support neurological research, where non-invasive, high-resolution access to brain structures is critically needed.

Published paper: Thermally Prolonged NIR-II Luminescence Lifetimes by Cross-Relaxation (2024)

Cover of the 2024 Annual ReportThis impact story is an extract from QUBIC’s 2024 Annual Report: read more.

Harnessing Red Light to Improve Honeybee Health and Honey Production

In 2024 a Translation Facilitation Project was awarded to harness red light to improve Honeybee health and honey production. Honeybees are vital to Australia’s agriculture and economy, supporting crop growth, livestock feed, and food production through pollination services valued at over $14 billion annually. Studies show that red light exposure may significantly enhance honeybee health. This project aimed to assess whether this could be utilised in cost effective ways in bee keeping practices.

This project was led in the field by Dr Nicolas Mauranyapin from QUBIC who worked together with Simon Chatburn (Head beekeeper) from HoneyHunters Australia. The team developed modifications to the HoneyHunter beehives to enable red light illumination and monitor hive vitality. These modifications have been installed in thirty hives in regional Queensland to test the effect of red light on bee heath and hive productivity.

Bees are critical for pollination in our natural parks and communities. However, biosecurity threats such as the Varroa mite are putting significant pressure on Australian bees, highlighting the importance of improving their resilience.

The Translation Facilitation Project supports QUBIC researchers in translating their work into impactful real-world applications.

Dr. Nicolas Mauranyapin is a postdoctoral fellow with over six years of post-PhD research experience specialising in optics, biosensing, bioimaging, quantum optics, and nanomechanics.

Image: Dr Nicolas Mauranyapin (left) and Mr Simon Chatburn (right) on site at HoneyHunters Australia apiary located in the Goondiwindi Region about 300km outside of Brisbane.

Quantum Microscopy Breakthrough Could Help Detect Hidden Threats in Our Food and Bodies

What if we could see the invisible? For example, the tiny molecules that signal disease or contamination without harming the cells we’re measuring.

Centre researchers from The University of Queensland have developed a new quantum-enhanced approach to Raman microscopy that uses quantum light to fingerprint molecules in biological samples in greater detail with less damage. This breakthrough could transform how we detect disease, monitor food safety, and study living cells in real time.

The microscope uses a special form of light called squeezed light that allows scientists to gather more information while avoiding damage and disruption on delicate samples. This is a turning point for studying living cells, where traditional imaging methods can be too harsh or too slow to capture fast-moving processes.

The technology builds on QUBIC’s mission to develop quantum tools that reveal how life works at the smallest scales. It’s part of a broader effort to understand how cells function, adapt, and sometimes fail, all insights that are essential for tackling diseases and improving health.

By combining quantum technologies with microscopy, the team has opened a new window into the living world. This technical achievement is an exciting new way to explore life, protect health, and respond to challenges we can’t yet see.

Published paper: Fast biological imaging with quantum-enhanced Raman microscopy (2024)

Cover of the 2024 Annual ReportThis impact story is an extract from QUBIC’s 2024 Annual Report: read more.

Cracking a Cancer Code: How Simulations Are Guiding Smarter Drug Design

Some of the most important breakthroughs in medicine happen at the tiniest scales, like inside our cells, where proteins quietly control life and disease. One such protein, NHE1, plays a key role in helping cancer cells survive in harsh environments.

In a study published in The Journal of Physical Chemistry B, Centre researchers from the University of Wollongong use powerful molecular simulations to reveal detailed insights into how this protein interacts with potential drug molecules. Their findings offer a detailed map of how to block NHE1’s activity, paving the way for more targeted and effective cancer treatments.

This work reflects QUBIC’s mission to understand life at the molecular level using advanced computational tools. While this study uses classical simulations, it lays the foundation for future quantum-enhanced approaches that could model even more complex biological systems with greater precision. By showing how drug molecules can latch onto NHE1 and shut it down, the research provides a critical piece of the puzzle in designing next-generation therapies, not just for cancer, but also for heart disease and other conditions where this protein plays a role.

By unlocking molecular-level insights through advanced simulation, this work lays the foundation for a new era of precision medicine.

Published paper: Ion Transport and Inhibitor Binding by Human NHE1: Insights from Molecular Dynamics Simulations and Free Energy Calculations (2024)

Cover of the 2024 Annual ReportThis impact story is an extract from QUBIC’s 2024 Annual Report: read more.

Queensland to quash carbon emissions under the new Quantum Decarbonisation Alliance

The Queensland government has awarded $10M to the Quantum Decarbonisation Alliance (QDA), a consortium of leading research and industry organisations in a mission to apply quantum technologies to solve critical decarbonisation challenges.  

New technologies are needed to reach net zero, and quantum technologies promise to play a pivotal role. The Alliance aims to drive significant long-term reductions in carbon emissions across energy, agriculture, resources, and carbon capture. 

The QDA brings together The University of Queensland, QUBIC, Griffith University, Australia’s national science agency CSIRO, PsiQuantum and 23 other partner organisations. 

Professor Warwick Bowen, QDA lead and Director of the Australian Research Council Centre of Excellence in Quantum Biotechnology, states: “This is an exciting time to be developing quantum technologies for decarbonisation. Achieving COP26 emissions targets requires huge technological advances to address computational challenges that exceed the capabilities of today’s supercomputers and to better locate and extract critical minerals.” 

According to McKinsey (2022), quantum computing could enable over 7 gigatons of CO2-equivalent abatement annually, reducing global greenhouse emissions by 18%.  

“Quantum computing offers transformative potential in developing innovative solutions to address the environmental challenges posed by energy-intensive industries. We are excited to support the Quantum Decarbonisation Alliance in driving Queensland’s decarbonization efforts and helping to shape a more sustainable future,” said Dr. Geoff Pryde, Senior Director of Technical Partnerships at PsiQuantum. 

The QDA is the sole recipient of the Queensland Government’s Quantum and Advanced Technologies Quantum Decarbonisation Mission Program, which is part of the state’s $83.7 million investment over five years for the Queensland Quantum and Advanced Technologies Strategy.  

The QDA will focus on applying quantum computing and sensing technologies to several key areas: 

  • Battery Materials: Quantum computing enabled precise simulations of molecular interactions, essential for developing higher density batteries for electric vehicles and storage. 
  • Transport Optimisation: Quantum computing optimisation for large-scale logistics networks, reducing fuel use and emissions.  
  • Catalyst Design: Quantum models to better simulate chemical reactions for green hydrogen production and carbon capture, improving efficiency  
  • Underground Autonomous Mining: Quantum inertial sensors for precise navigation in GPS-denied environments, for efficient underground extraction of rare critical minerals. 
  • Deep Ore Detection: Quantum magnetometers to detect weak magnetic fields from ore bodies, improving mining efficiency and reducing environmental impact. 
  • Greenhouse Gas Monitoring: Quantum sensors to measure trace greenhouse gases with high sensitivity, allowing real-time monitoring of emissions and carbon sequestration integrity  
  • Single Molecule Sensing: Quantum sensors to provide new insights into protein dynamics and interactions, improving catalyst design for low-energy industrial processes. 

This grant underscores Queensland’s commitment to becoming a global leader in quantum technologies and their application to critical challenges such as climate change. 

Contact: Professor Warwick Bowen, +61 (0)404 618722 / QUBIC Communications, connect.qubic@uq.edu.au